US Orthobiologics Market (Growth Factor, DBM, Bone Substitute, Cell-based Matrices) (2019-2023)

The U.S. Orthobiologics Market has, lately, become concentrated to sustain the growth by introducing various medical innovations.
By: Koncept Analytics
 
 
Spread the Word
Listed Under

Tag:
* Us Orthobiologics Market

Industry:
* Reports

Location:
* Delhi - Delhi - India

Subject:
* Reports

DELHI, India - April 1, 2019 - PRLog -- Orthobiologics are the biologically derived materials from the body to promote the repair and regeneration of musculoskeletal tissues. When they are used in higher concentrations than normally present in the body, they can potentially help speed up the healing process. The substances which are considered to be Orthobiologics are: Growth factors, DBM, Cell Based Matrices, Machined bone, Bone substitute and others. These Orthobiologics are capable of bone formation and encourage healing of fractures, nonunion, and repairing defects of various traumatic and non-traumatic conditions of skeletal system.

The U.S. Orthobiologics Market has, lately, become concentrated to sustain the growth by introducing various medical innovations. The healthcare and medical sector is rapidly growing due to increasing healthcare problems amongst people, especially old age people. The increased demand for growth factors and DBM from end- users segments such as hospitals and medical centers had a major contribution in the expansion of the U.S. Orthobiologics market.

The growth of the U.S. Orthobiologics market was attributable to the Factors such as rising burden of orthopedic injuries; increasing incidence of sports injuries and road accidents; increasing incidence of spinal fusion surgeries; risk factors associated with increasing aging population, obesity rate, & high incidence of musculoskeletal disorders; and growing patient preference for minimally invasive procedures.

The global Orthobiologics market was dominated by four key players: Medtronic, Johnson and Johnson, Sanofi S.A. and Zimmer Biomet. Whereas, the U.S. Orthobiologics market was majorly ruled by key players such as Medtronic, Johnson and Johnson, Stryker Corporation and NuVasive Inc. All these leading players had a major contribution in the growth of global as well the U.S. Orthobiologics market. Their effective strategy formulation and implementation has promoted to the expansion of the healthcare sector at a great extent.

List of Charts

Essentials for Orthobiologics
Types of Orthobiologics
Global Orthobiologics Market Forecast by Value (2018-2023)
The U.S. Orthobiologics Market by Value (2014-2018)
The U.S. Orthobiologics Market by Value (2014-2018)
The U.S. Orthobiologics Market Forecast by Value (2019-2023)
The U.S. Orthobiologics Market Value by Product (2018)
The U.S. Growth Factors Market by Value (2014-2018)
The U.S. Growth Factors Market Forecast by Value (2019-2023)
The U.S. DBM Market by Value (2014-2018)
The U.S. DBM Market Forecast by Value (2019-2023)
The U.S. Bone Substitute Market by Value (2014-2018)
The U.S. Bone Substitute Market Forecast by Value (2019-2023)
The U.S. Cell Based Bone Market by Value (2014-2018)
The U.S. Cell Based Bone Market Forecast by Value (2019-2023)
The U.S. Machined Bone Market by Value (2014-2018)
The U.S. Machined Bone Market forecast by Value (2019-2023)
The U.S. Allograft bone Market by Value (2014-2018)
The U.S. Allograft bone Market Forecast by Value (2019-2023)
The U.S. Platelets Concentrator Market by Value (2014-2018)
The U.S. Platelets Concentrator Market Forecast by Value (2019-2023)
The U.S. Ageing population (2014-2018)
The U.S. Healthcare Expenditure per Capita (2014-2018)
Global Orthobiologics Market Share by Company (2018)
The U.S. Orthobiologics Market Share by Company (2018)
Key Players - Market Cap Comparison
Johnson and Johnson Total Sales by Product Segments (2018)
Johnson and Johnson Total Sales and Net Earnings (2014-2018)
Johnson and Johnson R&D Expenditures (2016-2018)
Medtronic Total Sales by Product Segments (2018)
Medtronic Total Sales and Net Earnings (2014-2018)
Medtronic R&D Expenditures (2016-2018)
Stryker Corporation Sales by Segment (2018)
Stryker Corporation Net Sales and Net Earnings (2014-2018)
Stryker Corporation R&D Expenditure (2016-2018)
NuVasive Inc. Revenue by Segments (2018)
NuVasive Inc. Total Revenue and Net Income (2014-2018)
NuVasive Inc. R&D Expenditure (2016-2018)

List of Tables

Applications of Different Orthobiologics
Orthobiologics Treatments
Advantages and Disadvantages of Bone Grafts and Substitutes
Key Players – Revenue Comparison (2018)

For more Information:

http://www.konceptanalytics.com/Researchreport/us-orthobiologics-market-growth-factor-dbm-bone-substitute-cell-based-matrices-machined-bone-allograft-bone-industry-analysis-outlook-2019-2023-41601.aspx

Koncept Analytics

Vikas Gupta

(Business Development Manager)

FFCS-36, Ansal Plaza

Vaishali, Ghaziabad

U.P - 201010

Tele: +91-120-4130959

Mobile: +91-9871694789

Mail ID – vikas@konceptanalytics.com

Contact
Vikas Gupta
vikas@konceptanalytics.com
+91-9871694789
End
Email:***@konceptanalytics.com
Posted By:***@konceptanalytics.com Email Verified
Tags:Us Orthobiologics Market
Industry:Reports
Location:Delhi - Delhi - India
Subject:Reports
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse



Like PRLog?
9K2K1K
Click to Share